As COVID-19 becomes a “new norm” and the number of positive cases is not as high as it used to be, we still need to stay alert especially when it comes to those who are the most vulnerable to the possible negative consequences.
The...
The Effectiveness Bank features a collection of 45 hot topics – essays written by Drug and Alcohol Findings explaining the background and evidence relating to topics which sometimes prompt heated debate.
They are a popular way to get up to...
Policies that allow for alternatives to incarceration are a way to link individuals with substance use disorders to supportive treatment and social services. This proven approach increases the number of people in long term recovery and...
The Global Synthetic Drugs Assessment 2020 provides an analysis of the global synthetic drugs market.
Inequality in Smoking Cessation Clinical Trials – Exclusion of Smokers with Mental Health Disorders (MHDs)
The Global Drug Survey uses an anonymous online survey to conduct the world’s biggest drug survey.
The annual GDS survey runs from the middle of November each year for approximately 6 weeks.
GDS partners with global media giants to act as...
The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health and relationships.
Ov...
The fight against COVID-19 continues throughout the U.S., increasing stress and anguish among vulnerable populations struggling with substance use. Among those vulnerable populations, pregnant women present major concerns as they face an...
